Year density
3 results for “Target Oncol”. Showing 3 of 39,449.
Filters: query: Target Oncol
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
Oncol. 2022 Mar 24;15(1):34. doi: 10.1186/s13045-022-01252-0. Targeting
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Oncol Rep. 2023 Jun;25(6):539-547. doi: 10.1007/s11912-023-01382-9. Epub 2023 Mar 16. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions. Singh I(1), Singh
NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression.
Oncol. 2024 Oct 14;17(1):97. doi: 10.1186/s13045-024-01618-6. NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression. Wang X(1), Chai Y(1), Quan